Research output per year
Research output per year
Search results
-
2024
Assessing the impact of PCSK9 inhibitors in steatotic liver disease: a prospective observational cohort study (SIMPLE)
George, J., Leith, D., Dillon, J., Brennan, P., Handjiev, S. & Lynch, R., 29 Oct 2024, 23 p. University of Dundee.Research output: Other contribution
Open AccessFile20 Downloads (Pure) -
Increased risk of chronic kidney disease and mortality in a cohort of people diagnosed with metabolic dysfunction associated steatotic liver disease with hepatic fibrosis
Gurun, M. (Lead / Corresponding author), Brennan, P., Handjiev, S., Khatib, A., Leith, D., Dillon, J. F. & Byrne, C. J., 16 Apr 2024, In: PLoS ONE. 19, 4, 17 p., e0299507.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Citation (Scopus)70 Downloads (Pure) -
Intelligent Liver Function Testing (iLFT): An Intelligent Laboratory Approach to Identifying Chronic Liver Disease
Nobes, J., Leith, D., Handjiev, S., Dillon, J. F. & Dow, E. (Lead / Corresponding author), 4 May 2024, In: Diagnostics. 14, 9, 15 p., 960.Research output: Contribution to journal › Review article › peer-review
Open AccessFile1 Citation (Scopus)80 Downloads (Pure) -
2023
Efficacy and tolerability of PCSK9 inhibitors in real-world clinical practice
Devaiah, P., Handjiev, S. & George, J. (Lead / Corresponding author), 29 Nov 2023, (E-pub ahead of print) In: British Journal of Cardiology. 30, p. 153–6 4 p.Research output: Contribution to journal › Article › peer-review
Open Access